Amplifon SpAAMFPF 71 Days Payable is 74.09 as of Mar. 2026, which is 22% below its 10-year median of 95.34. GuruFocus rates AMFPF with a GF Score™ of 71/100 and a GF Value™ of $28.72 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 117 Medical Distribution companies, Amplifon SpA ranks better than 70.94% on this metric.
The historical rank and industry rank for Amplifon SpA's Days Payable or its related term are showing as below:
AMFPF'
s Days Payable Range Over the Past 10 Years
Min: 74.32 Med: 95.34 Max: 128.5
Current: 110.73
During the past 13 years, Amplifon SpA's highest Days Payable was 128.50. The lowest was 74.32. And the median was 95.34.
AMFPF's Days Payable is ranked better than 70.94% of 117
companies
in the Medical Distribution industry
Industry Median: 79.11
vs AMFPF: 110.73
Amplifon SpA's Days Payable
increased
from Mar. 2025 (71.50) to Mar. 2026 (74.09).
It may suggest that Amplifon SpAdelayed paying its suppliers.
Amplifon SpA Days Payable Related Terms
Amplifon SpA Days Payable Historical Data
* Premium members only.
The historical data trend for Amplifon SpA's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Amplifon SpA's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Amplifon SpA Days Payable vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Amplifon SpA's Days Payable distribution charts can be found below:
* The bar in red indicates where Amplifon SpA's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Amplifon SpA's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Amplifon SpA (AMFPF) has a Days Payable of 74.09 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Amplifon SpA and its competitors. This is 22% below median its historical median of 95.34. Over the past decade, Amplifon SpA's Days Payable has ranged from 74.32 to 128.50. According to the industry distribution chart, Amplifon SpA ranks #34 out of 117 companies in the Medical Distribution industry, placing it in the top 29.1%.
Is Amplifon SpA's Days Payable too high?
Amplifon SpA's current Days Payable of 74.09 is 22% below median its 10-year median of 95.34. Over the past 10 years, this metric has ranged from a low of 74.32 to a high of 128.50. The Medical Distribution industry median Days Payable is 79.11. Amplifon SpA's value of 74.09 is 6.3% below this industry median. Based on the distribution chart, Amplifon SpA ranks #34 out of 117 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Amplifon SpA has a GF Score™ of 71/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Amplifon SpA's Days Payable compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Amplifon SpA ranks #34 out of 117 companies for Days Payable. This puts Amplifon SpA in the upper half of its industry. The industry median Days Payable is 79.11. Amplifon SpA's value of 74.09 is 6.3% below this benchmark. Historically, Amplifon SpA's own Days Payable has ranged from 74.32 to 128.50 over the past decade. While the company's 10-year median is 95.34 vs. the industry median of 79.11, Amplifon SpA has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Distribution company?
The median Days Payable among Medical Distribution companies is 79.11, based on 117 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Amplifon SpA's current Days Payable of 74.09 is 6.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Amplifon SpA and its competitors. For the Medical Distribution industry, the median Days Payable is 79.11 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Amplifon SpA's current Days Payable is 74.09, which is 22% below median its own 10-year median of 95.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Amplifon SpA stock overvalued right now?
Based on GuruFocus' analysis, Amplifon SpA (AMFPF) is currently considered Possible Value Trap. The stock's GF Value™ is $28.72, compared to a current price of $11.21 — trading 61% below its estimated fair value. The current Days Payable is 74.09, which is 22% below median its 10-year median of 95.34 and 6.3% below the Medical Distribution industry median of 79.11. Amplifon SpA's overall GF Score™ is 71/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Amplifon SpA (AMFPF), the current Days Payable is 74.09 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Amplifon SpA (AMFPF) Overvalued in 2026?
Based on GuruFocus' analysis, Amplifon SpA stock appears to be undervalued.
The current stock price of $11.21 is trading 61% below its estimated GF Value™ of $28.72.
GuruFocus considers Amplifon SpA to be Possible Value Trap.
Key valuation signals for AMFPF:
Days Payable: 74.09 (22% below median its 10-year median of 95.34)
GF Value™: $28.72 vs. price of $11.21 (61% below fair value)
Industry Position: 6.3% below the Medical Distribution median (#34 of 117)
No single metric tells the full story. See the AMFPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Amplifon SpA provides customizable hearing solutions and services through a distribution network of network affiliates, corporate shops, franchises, and shop-in-shops. The company operates in three segments based on geography: the Americas; Europe, the Middle East, and Africa; and Asia-Pacific. It generates the majority of its revenue in the EMEA region. It operates under a variety of brands in these regions, including Amplifon, Beter Horen, Maxtone, and Miracle-Ear.
71GF Score
Get the complete analysis for AMFPF
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AMFPF has been successfully added to your 
